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Background: Widely observed excess mortality among women after coronary artery
bypass grafting is still largely unexplained, although case-mix factors have been
identified. We evaluated the contribution of perioperative complications to the risk
of 180-day mortality among women while adjusting for case-mix factors.
Methods: This is part of a prospective, 1-year nationwide Israeli coronary artery
bypass graft study of 1029 female and 3806 male patients. Deaths within 180 days
were independently ascertained. Case-mix risk strata were obtained from a pooled
Cox survival model (including all subjects and study variables) by using the
adjusted coefficients corresponding to the case-mix factors within the model. Sex-
specific mortality associated with perioperative complications was evaluated within
the strata. In addition, sex-specific Cox models were constructed.
Results: Higher mortality among women compared with that among men was sig-
nificant within the pooled model (hazard ratio, 1.4; P = .038) and was evident early
in the postoperative period. Women tended to cluster in the highest risk quartile
compared with men (39.8% vs 20.9%, P < .001). However, although the incidence
of perioperative complications was similar for the 2 sexes, the associated mortality
for a given perioperative complication was higher among women. Sex-specific Cox
models confirmed the above findings. For example, the hazard ratio for women with
low postoperative hemoglobin was 6.9, whereas for men, the hazard ratio was 3.9.
Conclusions: The role of perioperative factors in the excess mortality among
women after coronary artery bypass grafting shifts the focus of attention from the
selection of women for the operation to the in-hospital experience. Improving the
outcome for women will entail efforts to prevent complications in the perioperative
period.
Outcome studies in patients undergoing coronary artery bypassgrafting (CABG) have shown consistently that women are athigher risk for postoperative mortality.1-11 Several factors associ-ated with the excess mortality in women are discussed in the lit-erature, suggesting a greater severity of illness before theoperation. Higher prevalence of known risk factors, such as older
age,1-9 diabetes mellitus,1-6 obesity,5-7 hypertension,5-8 renal dysfunction,5 and
advanced coronary artery disease,6,12 were found in women. Delayed referral of
women for surgical intervention was also cited as a possible explanation for sex dif-
ferences in mortality.13 Smaller coronary vessels in women were thought to predis-
pose them to technical difficulties during the operation, resulting in incomplete
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revascularization14 and reduced use of arterial grafts.2,10
However, few reports have focused on sex differences in
perioperative complications. Utley and colleagues3 com-
pared the incidence of postoperative complications without
adjustment for case-mix factors.
The present study is part of a nationwide study of
patients undergoing CABG in 1994, with complete follow-
up of patients from admission to discharge and mortality up
to 180 days after surgical intervention. The analysis
attempts to evaluate the independent contribution of periop-
erative complications to mortality among women adjusting
for on-admission risk.
Methods
This report is a part of the National Israeli CABG Study, which
was carried out in all 14 cardiac surgery departments in Israel in
1994. All the patients undergoing isolated CABG during the
period from January 1, 1994, to December 31, 1994, were
included. The present report was based on 4835 patients (3806
men and 1029 women), representing 95% of the total target popu-
lation. The 265 patients who had not completed the baseline inter-
view because of staff vacations were excluded from the analysis.
A detailed description of the study is given elsewhere.15
In brief, information was collected prospectively by a team of
specially trained nurses. The information included patient’s demo-
graphic characteristics and health practices, which were obtained
from a personal interview before the operation. The clinical his-
tory was obtained both from personal interview and medical
records, and the severity of coronary disease was verified with
catheterization reports. Information on the operative variables was
extracted from the operation reports filled out by the surgeons.
Information on the postoperative variables was obtained by means
of daily follow-up of the patients until discharge or death,
whichever was earlier. Data collection was standardized and
supervised throughout the year. The study was monitored by a
steering committee consisting of the heads of all cardiac surgery
departments in the country.
Six-month mortality was chosen as the outcome of interest,
assuming that within this time frame, death could be reasonably
attributed to the surgical procedure.
Deaths were verified by linkage to the national death records,
regardless of hospitalization status.
Survival patterns among men and women until the 180th post-
operative day were evaluated by using the Kaplan-Meier estimate.
A pooled Cox model including both sexes and all study vari-
ables (case-mix factors and perioperative complications) was con-
structed in the usual manner to estimate the independent effect of
perioperative factors on mortality. Similarly, 2 sex-specific models
were developed. The models’ performance was evaluated with the
Harrel c statistics.16
The pooled model was used for comparison with the sex-spe-
cific models and to form on-admission risk strata by using the par-
tial score corresponding to the β-coefficients of the case-mix
factors within the model, excluding the sex variable. This partial
score reflected the net effect of case-mix factors because they were
already adjusted for the later complications. The sex-specific inci-
dence and effect of perioperative factors were then evaluated
within quartiles of risk. Finally, 2 sex-specific Cox models were
constructed, including variables significant in either model.
Results
Of the 4835 CABG operations in Israel in 1994, only 1029
(21.3%) were performed in women. The mortality rate for
Figure 1. Observed 180-day survival after CABG: women versus men.
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the total population within 180 days after CABG was 5.1%,
which is similar to that of other published reports.17,18 The
corresponding mortality rates in women and men were
7.8% and 4.4%, respectively (relative risk, 1.8; P < .01).
The Kaplan-Meier survival curves for women and men are
presented in Figure 1, demonstrating that the divergence of
the survival curve for women occurred early in the periop-
erative period. Later, the 2 survival curves run parallel.
Women had a different social profile than men (univari-
ate analysis, Appendix 1), being older, less educated, more
of immigrant origin, less gainfully employed, and less fre-
quently employed in academic professions and more fre-
quently having no spouse or living alone. However,
sociodemographic factors did not seem to affect 180-day
mortality. Women presented with higher proportions of
the majority of screened preoperative clinical factors but
the same proportion of perioperative complications. The
absolute effect of single preoperative factors on mortality
among women relative to men varied only slightly. By con-
trast, for perioperative factors, the mortality among women
was extremely high.
The relative effect of various factors on mortality within
the sexes was strongly affected by the high mortality in the
reference group among women. For example, although the
absolute mortality rate in women with 3-vessel disease and
left main involvement was 15.7% versus 7.4% in men, the
relative risks for the 2 sex groups were similar (2.9 and 2.6,
respectively) because of the high mortality rate in the refer-
ence group among women (Appendix 1).
A pooled multivariate Cox model was constructed to
evaluate the independent effect of all study variables on
180-day mortality. Generally, it demonstrated stronger
effects for perioperative complications compared with case-
mix factors. The relative risk associated with female sex
TABLE 1. Comparison of 3 Cox models for mortality risk within 180 days after CABG: ISCAB, 1994
All Patients Men Women
Variable HR* P value HR* P value HR* P value
Case mix
Female sex 1.35 .038 — — — —
Age ≥75 y 1.83 .000 (1.38) .095 3.30 .000
Emergency operation 3.67 .000 4.77 .000 (2.33) .084
Urgent operation 1.33 .045 (1.36) .098 (1.39) .221
Cancer 2.45 .019 2.86 .028 (2.33) .274
Extreme BMI† 2.08 .013 (1.14) .801 4.46 .000
Diabetes mellitus 1.84 .000 1.55 .010 2.94 .000
Severe LVD 1.70 .004 1.86 .007 (1.08) .584
Moderate LVD 1.41 .046 1.76 .007 (1.20) .209
Renal dysfunction 1.69 .001 1.92 .000 (1.27) .613
Physical activity‡ 0.43 .000 0.46 .000 0.27 .007
Operative
Intraoperative complications§ 2.62 .000 2.40 .000 5.54 .000
Intraoperative IABP 1.91 .002 2.47 .000 (0.81) .640
No crossclamp 1.84 .048 (1.74) .162 (1.76) .264
Incomplete revascularization 1.72 .000 1.77 .001 (1.26) .393
Postoperative predischarge period
Hemoglobin <8 mmol/L 4.01 .000 3.93 .000 6.86 .000
Cerebrovascular accident 3.56 .000 4.25 .000 2.18 .050
On respirator ≥24 h 2.93 .000 2.42 .000 3.67 .000
Myocardial infarction 2.92 .000 2.23 .009 6.68 .000
Heart failure 2.43 .000 2.42 .000 2.44 .007
Arrhythmia 1.79 .004 1.93 .007 1.97 .054
Additional operation 1.71 .004 1.86 .006 (1.56) .183
Steroid therapy 1.64 .001 1.69 .004 (1.53) .148
Transfusions ≥5 portions (1.06) .692 (0.92) .705 1.92 .047
c statistics 0.900 0.899 0.915
LVD, Left ventricular dysfunction; BMI, body mass index; IABP, intra-aortic balloon pump.
*Hazard ratio derived from the Cox model approximates the relative risk.
†The model included a category for missing values of BMI, which were significantly associated with mortality.
‡In the model physical activity entered as a protective factor.
§Definition on the basis of specific diagnoses, such as intraoperative massive bleeding and additional grafts.
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after controlling for all significant factors within the model
was 1.35 (P = .038, Table 1).
The pooled model was used to form on-admission risk
quartiles by using the β-coefficients of the case-mix factors
within the model. These quartiles were used to compare the
sexes for the frequency and effect of perioperative factors.
More women relative to men were observed in the high-risk
quartile (39.8% vs 20.9%, P < .001). Perioperative compli-
cations occurred with the same frequency among the sexes
within corresponding levels of risk. However, in the highest
quartile the associated mortality was significantly higher
among women relative to men (Figure 2) for such factors as
prolonged mechanical ventilation (51.6% vs 34.4%, P =
.017) and need for blood transfusions (47.5% vs 25.3%, P
= .001). Great differences in mortality rates were also
observed for myocardial infarction, additional operation,
heart failure, urine volume of less than 1000 mL, and
steroid therapy. However, they did not achieve statistical
significance because of small numbers.
Finally, sex-specific Cox models (Table 1) reemphasized
the strong effect of perioperative complications on mortal-
ity, especially among female patients. Among these factors
in the female model were intraoperative complications
(hazard ratio [HR], 5.5; P < .000), postoperative low hemo-
globin (HR, 6.9; P < .000), postoperative myocardial infarc-
tion (HR, 6.7; P = .009), time on respirator of greater than
24 hours (HR, 3.7; P < .000), and transfusions over 5 por-
tions (HR, 1.9; P = .05). In addition, other interesting find-
ings in the female model were the unique effect of extreme
body mass index and age over 75 years.
Discussion
We examined the hypothesis that perioperative factors were
especially important when attempting to explore sex differ-
ences in mortality because significant sex differences were
found in the operative technique: incomplete revasculariza-
tion in women14 and diminished use of internal thoracic
artery grafts,2 as well as differences in mortality related to
the prevalent use of exclusive venous grafting in women.10
Proposed explanations in the literature for sex differ-
ences in mortality after CABG usually center on a more
severe patient profile among women.7 It is assumed that
residual variability in mortality after adjusting for case-mix
is usually a result of patient care, but surgical technique is
hard to quantify, and meaningful data on the operation and
the postoperative period are hard to get. However, there is
evidence from published reports that patient experience in
the hospital is important. Duration of the operation, type of
grafting used, reexploration for bleeding, intraoperative
complications, inability to wean patients off respirators,
need for inotropic drugs and blood transfusions, and devel-
opment of wound infections have all been shown to be asso-
ciated with mortality after CABG.19-23 In a previous report
we suggested that not all complications during the opera-
tion and the perioperative period could be attributed to
patient inherent risk at the time of the operation.15
Furthermore, the sequential addition of the operative and
postoperative factors to the case-mix characteristics sug-
gested an independent effect of these factors on mortality.
Using detailed information on inherent patient character-
istics at entry to the hospital and during the operation and
Figure 2. Mortality at 180 days for perioperative complications among women versus men in the highest quartile of
on-admission risk.
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the postoperative period enabled us to isolate the effect of
perioperative factors while adjusting for patients’ on-admis-
sion risk within a Cox model.
Our study confirmed previous reports demonstrating that
risk factors are more prevalent in women than in men before
the operation.1-11 However, in contrast to other studies,3 we
found no significant sex differences in the incidence of
postoperative complications.
The main finding in the present study was that perioper-
ative complications tended to be more lethal for women.
For example, women with postoperative myocardial infarc-
tion had a 3-fold risk of dying relative to men with the same
complication, and those with low postoperative hemoglobin
or multiple transfusions had twice the probability of dying
relative to men (Table 1). Although our study sample
included 1029 women, it is possible that with a larger sam-
ple size some additional risk factors would have entered the
female model.
The differential effect on mortality for perioperative fac-
tors was especially prominent among patients in the upper
quartile of on-admission risk. Although the overall sex-spe-
cific crude 180-day mortality rates were relatively low
(7.8% vs 4.4% for women and men, respectively), the rates
associated with perioperative complications in the upper
risk quartile were of a different order of magnitude, espe-
cially for women: with additional surgery, 63% mortality;
with prolonged mechanical ventilation, 51%; with multiple
transfusions, 48%; and with low hemoglobin, 40% (Figure
2). The fact that perioperative complications were less well
tolerated by female patients may be due in part to the inher-
ent risk of female patients undergoing an operation.
However, the possibility that surgeons experienced more
difficulties in managing complications in high-risk female
patients should also be considered.
Recently, publications have shifted the attention con-
cerning mortality among women undergoing CABG from a
biased selection of female patients for surgical intervention
to the actual surgical event. O’Connor and colleagues24
found that interventions by reviewing operative technique
resulted in reducing mortality after CABG. Petro and
coworkers25 reported encouraging results from minimally
invasive procedures among women. However, although the
standard CABG is a common procedure, our findings lend
support to the continuing efforts to manage female patients
with extra care to avoid perioperative complications.
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APPENDIX 1. Univariate analysis of 180-day mortality after CABG among women versus men (only significant associations
in either sex): ISCAB, 1994
Men Women
Risk factors n Mortality rate (%) Cox HR n Mortality rate (%) Cox HR
Case-mix factors
Age (y)
<65 1959 2.8 1.0 334 5.4 1.0
65-74 1431 5.2 1.9† 532 7.7 1.4
≥75 416 9.9 3.7† 163 12.9 2.4†
Extreme BMI (<20, >35)
No 3584 3.8 1.0 887 6.1 1.0
Yes 73 5.5 1.4 56 16.1 2.8†
Missing 149 18.8 5.5† 86 19.8 3.5†
Physical activity
No 1962 5.1 1.0 749 8.8 1.0
Yes 1717 2.0 0.4† 253 2.0 0.2†
Hospitalization in past 2 years
No 3285 3.6 1.0 807 7.7 1.0
Yes (≥3) 521 9.0 2.7† 222 8.1 1.0
Type of operation
Elective 2360 3.0 1.0 519 5.0 1.0
Urgent 1370 6.0 2.0† 478 9.8 2.0*
Emergency 76 22.4 8.9† 32 21.9 4.9†
Recent myocardial infarction
No 3708 4.3 1.0 995 7.5 1.0
Yes 98 10.2 2.4† 34 14.7 2.0
Left ventricle dysfunction
No 3241 3.3 1.0 746 6.9 1.0
Moderate 350 9.4 2.9† 163 9.8 1.4
Severe 215 13.0 4.1† 120 10.0 1.4
Extent of coronary disease
1- to 2-vessel disease 1722 2.4 1.0 440 5.9 1.0
1- to 2-vessel disease with LMD 373 5.9 2.1† 142 5.6 0.9
3-vessel disease without LMD 1468 5.4 1.9† 377 9.3 1.6*
3-vessel disease with LMD 243 7.4 2.6† 70 15.7 2.9†
Diabetes mellitus
No 2755 3.7 1.0 642 4.7 1.0
Yes 1051 6.5 1.8† 387 12.9 2.8†
Arrhythmia
No 3307 3.9 1.0 859 7.6 1.0
Yes 499 7.8 2.0† 170 8.8 1.1
Peripheral vascular disease
No 3448 3.9 1.0 940 7.8 1.0
Yes 358 9.5 2.5† 89 7.9 1.0
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APPENDIX 1. Continued
Men Women
Risk factors n Mortality rate (%) Cox HR n Mortality rate (%) Cox HR
Chronic obstructive pulmonary disease
No 3581 4.1 1.0 975 7.9 1.0
Yes 225 10.2 2.6† 54 5.6 0.7
History of cerebrovascular disease
No 3526 4.0 1.0 943 7.5 1.0
Transient ischemic attack 93 8.6 2.1* 32 6.2 0.8
Cerebrovascular accident 184 9.8 2.5† 54 13.0 1.8
Renal dysfunction
No 3343 3.3 1.0 968 7.5 1.0
Yes 463 13.0 4.1† 61 11.5 1.5
Perioperative factors
Intraoperative complications‡
No 3583 3.5 1.0 967 6.1 1.0
Yes 223 19.3 6.3† 62 32.3 6.3†
Intraoperative IABP
No 3723 3.7 1.0 1000 6.6 1.0
Yes 83 38.5 13.5† 29 48.3 10.1†
Type of graft
Others 3559 3.8 1.0 925 7.3 1.0
Vein only 247 13.4 3.7† 104 11.5 1.6
Crossclamp time per graft
≤25 min 3152 4.0 1.0 851 7.5 1.0
>25 min 391 7.4 2.1† 103 7.8 1.2
No crossclamp 123 5.7 1.6 27 18.5 2.9*
Incomplete revascularization
No 3017 3.7 1.0 802 6.7 1.0
Yes 789 7.3 2.0† 227 11.5 1.7*
Postoperative myocardial infarction
No 3643 4.0 1.0 980 6.7 1.0
Yes 163 14.8 3.9† 49 28.6 4.9†
Postoperative heart failure 
No 3739 3.9 1.0 993 6.2 1.0
Yes 67 35.8 11.0† 36 50.0 10.7†
Postoperative on respirator for >24 h
No 3422 2.4 1.0 903 4.1 1.0
Yes 384 22.7 10.5† 126 34.1 9.8†
Postoperative stroke 
No 3710 3.7 1.0 1000 6.9 1.0
Yes 96 33.3 10.3† 29 37.9 6.4†
Urine volume <1000 mL
No 3594 3.8 1.0 952 6.5 1.0
Yes 212 14.6 4.1† 77 23.4 4.0†
Additional operation
No 3635 3.5 1.0 974 5.2 1.0
Yes 171 25.1 8.3† 55 52.7 13.8†
Hemoglobin <8 mmol/L
No 3545 3.6 1.0 948 6.0 1.0
Yes 261 16.1 5.0† 81 28.4 5.8†
Postoperative intestinal bleeding
No 3693 4.2 1.0 1013 7.3 1.0
Yes 113 10.6 2.5† 16 37.5 6.1†
Mediastinitis or sepsis
No 3712 3.6 1.0 985 5.9 1.0
Yes 94 38.3 12.4† 44 47.7 8.3†
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APPENDIX 1. Continued
Men Women
Risk factors n Mortality rate (%) Cox HR n Mortality rate (%) Cox HR
Transfusions (≥5 portions)
No 3321 3.3 1.0 915 4.8 1.0
Yes 485 12.6 4.1† 114 31.6 7.6†
Steroid therapy
No 3112 3.3 1.0 858 5.9 1.0
Yes 694 9.4 2.9† 171 17.0 3.0†
Postoperative arrhythmia 
No 1837 2.0 1.0 467 3.9 1.0
Yes 1969 6.8 3.5† 562 11.0 3.0†
BMI, Body mass index; LMD, left main disease; IABP, intra-aortic balloon pump.
Missing values are not presented in the table. *.001 < P < .05; †P ≤ .001.
‡Definition on the basis of specific diagnoses, such as intraoperative massive bleeding and additional grafts.
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